Dr. Salvatore Brugaletta

Publicaciones destacadas

• Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study

  Autores: Ariotti S, Ortega-Paz L, van Leeuwen M, Brugaletta S, Leonardi S, Akkerhuis KM, Rimoldi SF, Janssens G, Gianni U, van den Berge JC, Karagiannis A, Windecker S, Valgimigli M, HI-TECH Investigators.

  Referencia: Jacc-Cardiovascular Interventions 2018.

• Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial

  Autores: Varenne, Olivier; Cook, Stephane; Sideris, Georgios; Kedev, Sasko; Cuisset, Thomas; Carrie, Didier; Hovasse, Thomas; Garot, Philippe; El Mahmoud, Rami; Spaulding, Christian; Helft, Gerard; Diaz Fernandez, Jose F.; Brugaletta, Salvatore; Pinar-Bermudez, Eduardo; Mauri Ferre, Josepa; Commeau, Philippe; Teiger, Emmanuel; Bogaerts, Kris; Sabate, Manel; Morice, Marie-Claude; Sinnaeve, Peter R.;.

  Referencia: Lancet 2018.

• Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold Thrombosis

  Autores: Ellis, Stephen G.; Steffenino, Giuseppe; Kereiakes, Dean J.; Stone, Gregg W.; van Geuns, R. J.; Abizaid, Alexandre; Nef, Holger; Cortese, Bernardo; Testa, Luca; Menichelli, Maurizio; Tamburino, Corrado; Gori, Tommaso; Kimura, Takeshi; Serruys, Patrick W.; Brugaletta, Salvatore; Sabate, Manel; Gao, Run-Lin;.

  Referencia: Jacc-Cardiovascular Interventions 2017.

• Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score.

  Autores: Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S .

  Referencia: Eurointervention 2017.

• Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI

  Autores: Davies, J. E.; Sen, S.; Dehbi, H. -M.; Al-Lamee, R.; Petraco, R.; Nijjer, S. S.; Bhindi, R.; Lehman, S. J.; Walters, D.; Sapontis, J.; Janssens, L.; Vrints, C. J.; Khashaba, A.; Laine, M.; Van Belle, E.; Krackhardt, F.; Bojara, W.; Going, O.; Harle, T.; Indolfi, C.; Niccoli, G.; Ribichini, F.; Tanaka, N.; Yokoi, H.; Takashima, H.; Kikuta, Y.; Erglis, A.; Vinhas, H.; Silva, P. Canas; Baptista, S. B.; Alghamdi, A.; Hellig, F.; Koo, B. -K.; Nam, C. -W.; Shin, E. -S.; Doh, J. -H.; Brugaletta, S.; Alegria-Barrero, E.; Meuwissen, M.; Piek, J. J.; van Royen, N.; Sezer, M.; Di Mario, C.; Gerber, R. T.; Malik, I. S.; Sharp, A. S. P.; Talwar, S.; Tang, K.; Samady, H.; Altman, J.; Seto, A. H.; Singh, J.; Jeremias, A.; Matsuo, H.; Kharbanda, R. K.; Patel, M. R.; Serruys, P.; Escaned, J.;.

  Referencia: New England Journal Of Medicine 2017.

• Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial

  Autores: Sabaté M, Brugaletta S, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, van Es GA, Backx B, Valgimigli M, Serruys PW .

  Referencia: Lancet 2016.

• Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial

  Autores: Sabate, Manel; Windecker, Stephan; Iniguez, Andres; Okkels-Jensen, Lisette; Cequier, Angel; Brugaletta, Salvatore; Hofma, Sjoerd H.; Raeber, Lorenz; Christiansen, Evald Hoi; Suttorp, Maarten; Pilgrim, Thomas; van Es, Gerrit Anne; Sotomi, Yohei; Garcia-Garcia, Hector M.; Onuma, Yoshinobu; Serruys, Patrick W.;.

  Referencia: European Heart Journal 2016.

• Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings

  Autores: Räber L, Brugaletta S, Yamaji K, O'Sullivan CJ, Otsuki S, Koppara T, Taniwaki M, Onuma Y, Freixa X, Eberli FR, Serruys PW, Joner M, Sabaté M, Windecker S .

  Referencia: Journal Of The American College Of Cardiology 2015.

• Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-Year results of a propensity score matching comparison: the BVS-examination study (Bioresorbable Vascular Scaffold-a clinical

  Autores: Brugaletta S., Gori T., Low A.F., Tousek P., Pinar E., Gomez-Lara J., Scalone G., Schulz E., Chan M.Y., Kocka V., Hurtado J., Gomez-Hospital J.A., Münzel T., Lee C.H., Cequier A., Valdés M., Widimsky P., Serruys P.W., Sabaté M..

  Referencia: Jacc-Cardiovascular Interventions 2015.

• The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial

  Autores: Sabate, Manel; Brugaletta, Salvatore; Cequier, Angel; Iniguez, Andres; Serra, Antonio; Hernadez-Antolin, Rosana; Mainar, Vicente; Valgimigli, Marco; Tespili, Maurizio; Den Heijer, Pieter; Bethencourt, Armando; Vazquez, Nicolas; Backx, Bianca; Serruys, Patrick W.

  Referencia: Jacc-Cardiovascular Interventions 2014.